Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study of cannabidiol as treatment for early psychosis

Trial Profile

A study of cannabidiol as treatment for early psychosis

Planning
Phase of Trial: Phase I

Latest Information Update: 17 Dec 2018

At a glance

  • Drugs Cannabidiol (Primary)
  • Indications Psychotic disorders
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 17 Dec 2018 According to an INSYS Therapeutics, Inc. media release, this study is expected to be opened in the first half of 2019.
    • 15 Sep 2018 New trial record
    • 04 Sep 2018 According to an INSYS Therapeutics media release, this trial is being conducted under collaboration with the University of California (UC) San Diego School of Medicines Center for Medicinal Cannabis Research (CMCR) and is expected to commence in 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top